title: Call to action: finding solutions for the drug shortage crisis in the United States.
abstract: In their article in this issue of CPT, Woodcock and Wosinska are the first to clearly outline the quality and manufacturing problems causing drug shortages of generic injectables. These authors have focused on the main issue, namely, that manufacturing problems and the lack of incentives for quality products are the primary reasons for most recent shortages of generic injectable drugs.
authors: Drug Information Service, University of Utah, Salt Lake City, Utah, USA. erin.fox@hsc.utah.edu
authors: E R
authors: ER
authors: Fox
authors: L S
authors: LS
authors: Tyler
mesh_terms: D004345:Drug Industry / Q000191:economics*; D016568:Drugs, Generic / Q000191:economics* / Q000600:supply & distribution*; D006801:Humans
chemical_list: D016568:Drugs, Generic